BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11696372)

  • 1. Reversible inhibition of cathepsin L-like proteases by 4-mer pseudopeptides.
    Lecaille F; Cotton J; McKerrow JH; Ferrer-Di Martino M; Boll-Bataillé E; Gauthier F; Lalmanach G
    FEBS Lett; 2001 Nov; 507(3):362-6. PubMed ID: 11696372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids.
    Lecaille F; Authié E; Moreau T; Serveau C; Gauthier F; Lalmanach G
    Eur J Biochem; 2001 May; 268(9):2733-41. PubMed ID: 11322895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of a cathepsin L-like cysteine protease by a chimeric propeptide-derived inhibitor.
    Godat E; Chowdhury S; Lecaille F; Belghazi M; Purisima EO; Lalmanach G
    Biochemistry; 2005 Aug; 44(31):10486-93. PubMed ID: 16060657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases.
    Serveau C; Lalmanach G; Hirata I; Scharfstein J; Juliano MA; Gauthier F
    Eur J Biochem; 1999 Jan; 259(1-2):275-80. PubMed ID: 9914503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
    Lynas JF; Hawthorne SJ; Walker B
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S1 subsite specificity of a recombinant cysteine proteinase, CPB, of Leishmania mexicana compared with cruzain, human cathepsin L and papain using substrates containing non-natural basic amino acids.
    Alves LC; Melo RL; Sanderson SJ; Mottram JC; Coombs GH; Caliendo G; Santagada V; Juliano L; Juliano MA
    Eur J Biochem; 2001 Mar; 268(5):1206-12. PubMed ID: 11231271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of cysteine proteinases responsible for digestive proteolysis in guts of larval western corn rootworm (Diabrotica virgifera) by expression in the yeast Pichia pastoris.
    Bown DP; Wilkinson HS; Jongsma MA; Gatehouse JA
    Insect Biochem Mol Biol; 2004 Apr; 34(4):305-20. PubMed ID: 15041015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of trypanosomal cysteine proteinases by their propeptides.
    Lalmanach G; Lecaille F; Chagas JR; Authié E; Scharfstein J; Juliano MA; Gauthier F
    J Biol Chem; 1998 Sep; 273(39):25112-6. PubMed ID: 9737969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the S(2) subsite specificities of the recombinant cysteine proteinases CPB of Leishmania mexicana, and cruzain of Trypanosoma cruzi, using fluorescent substrates containing non-natural basic amino acids.
    Alves LC; Melo RL; Cezari MH; Sanderson SJ; Mottram JC; Coombs GH; Juliano L; Juliano MA
    Mol Biochem Parasitol; 2001 Oct; 117(2):137-43. PubMed ID: 11606223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new class of nonpeptidic inhibitors of cruzain.
    Brak K; Doyle PS; McKerrow JH; Ellman JA
    J Am Chem Soc; 2008 May; 130(20):6404-10. PubMed ID: 18435536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
    Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and
    Boudreau PD; Miller BW; McCall LI; Almaliti J; Reher R; Hirata K; Le T; Siqueira-Neto JL; Hook V; Gerwick WH
    J Med Chem; 2019 Oct; 62(20):9026-9044. PubMed ID: 31539239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.
    Huang L; Ellman JA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2993-6. PubMed ID: 12270191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors.
    Yadav MR; Shinde AK; Chouhan BS; Giridhar R; Menard R
    J Enzyme Inhib Med Chem; 2008 Apr; 23(2):190-7. PubMed ID: 18343903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
    Therrien C; Lachance P; Sulea T; Purisima EO; Qi H; Ziomek E; Alvarez-Hernandez A; Roush WR; Ménard R
    Biochemistry; 2001 Mar; 40(9):2702-11. PubMed ID: 11258881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing cathepsin K activity with a selective substrate spanning its active site.
    Lecaille F; Weidauer E; Juliano MA; Brömme D; Lalmanach G
    Biochem J; 2003 Oct; 375(Pt 2):307-12. PubMed ID: 12837132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
    Crawford C; Mason RW; Wikstrom P; Shaw E
    Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of peptidyl ene diones: selective inactivators of the cysteine proteinases.
    Darkins P; Gilmore BF; Hawthorne SJ; Healy A; Moncrieff H; McCarthy N; McKervey MA; Brömme D; Pagano M; Walker B
    Chem Biol Drug Des; 2007 Mar; 69(3):170-9. PubMed ID: 17441903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors.
    Sartori GR; Leitão A; Montanari CA; Laughton CA
    PLoS One; 2019; 14(12):e0222055. PubMed ID: 31856175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.